Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism KRAS G12C inhibitors(GTPase KRas G12C inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | IND Approval | CN | 28 Jun 2022 | |
Colorectal Cancer | Preclinical | - | 08 Dec 2023 | |
Lung Cancer | Preclinical | - | 08 Dec 2023 |